Report of the GUDID Clinically Relevant Size (CRS) Work Group

AHRMM’s Issues & Legislative Committee issued the following Statement on Pricing Transparency approved by AHRMM Board of Directors:<

The FDA UDI ruling has finally arrived - the proposed rule has published.

AHRMM's Cost, Quality, and Outcomes (CQO) Movement will provide training and education to help supply chain professionals make the correlation…

The final regulations that provide guidance on the excise tax imposed on the sale of certain medical devices, enacted by the Health Care and Educ

An announcement of the Final Rule issued by the IRS.

The Strategic Marketplace Initiative (SMI) is a consortium of healthcare supply ch